Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The SEAMLESS Study: A Pragmatic Multi-Site Randomized Waitlist-Controlled Trial of a Smartphone App-Based Mindfulness Intervention for French and English Speaker Cancer Survivors

NCT05470010 is registered in ClinicalTrials.gov with Canadian Cancer Trials Group as lead sponsor.

NCT NCT05470010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05470010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The SEAMLESS Study: A Pragmatic Multi-Site Randomized Waitlist-Controlled Trial of a Smartphone App-Based Mindfulness Intervention for French and English Speaker Cancer Survivors
Lead sponsor
Canadian Cancer Trials Group
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 7, 2025
Completion date
December 31, 2026
Enrollment
300 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, psychological